Trimerised apolipoprotein A1
Alternative Names: Trimeric Apo A-I; Trimeric ApoA-1; Trimeric apolipoprotein A1Latest Information Update: 01 Aug 2007
At a glance
- Originator Borean Pharma
- Class
- Mechanism of Action Apolipoprotein A-I stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Atherosclerosis; Multiple sclerosis; Rheumatoid arthritis
Most Recent Events
- 01 Aug 2007 No development reported - Preclinical for Atherosclerosis in Denmark (unspecified route)
- 01 Aug 2007 No development reported - Preclinical for Multiple sclerosis in Denmark (unspecified route)
- 01 Aug 2007 No development reported - Preclinical for Rheumatoid arthritis in Denmark (unspecified route)